"Patients with anti-AQP4-Ab may basically need long-term relapse prevention, because they surely experience much higher relapse activity, with much worse neurological disturbance…In MOGAD patients, ...

Clinical Presentation Common symptoms of NMOSD result from damage to the optic nerve, spinal cord, and brainstem. These include optic neuritis with symptoms of loss or blurred vision in 1 or both eyes ...

In an exploratory study, serum levels of glial fibrillary acidic protein (GFAP) appeared to be predictive of disease severity and prognosis in patients with aquaporin-4 (AQP4)-immunoglobulin G (IgG) ...

Please provide your email address to receive an email when new articles are posted on . Become familiar with antibody-mediated myelin oligodendrocyte glycoprotein and neuromyelitis optica spectrum ...

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disorder that mostly affects your eyes and spinal cord. Your immune system attacks a specific protein, called aquaporin-4 (AQP4). The ...

Neuromyelitis optica spectrum disorder (NMOSD) is neuroinflammatory disease characterized by optic neuritis and myelitis with presence of anti-aquaporin-4 (AQP4) antibodies. Satralizumab is an anti-IL ...

Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis to be presented in EURETINA late-breaking session Expanded data analysis from Phase 3 Stage 1 DIAMOND program for OCS-01 ...

ZUG, Switzerland, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic diseases with significant ...

Area postrema syndrome is associated with uncontrollable hiccuping or vomiting. It is a clinical feature of another condition, called neuromyelitis optica spectrum disorder (NMOSD). A person who ...

Transverse myelitis in a patient with neuromyelitis optica spectrum disorder Three agents were recently FDA approved for NMOSD in adults who are AQP4 antibody positive: eculizumab, inebilizumab-cdon, ...